To date, dulaglutide, semaglutide, and tirzepatide have been the three predominant GLP-1 therapeutics employed in the treatment of T2DM, and their applications have been broadened to include weight management
Taken orally, these medications, respectively, stimulate the pancreas to produce more insulinthe hormone that helps the bodys cells suck in excess glucose in the bloodstreamand help lower the bodys overall level of blood sugar
Signal integration in the endoplasmic reticulum unfolded protein response
Injection or Oral Two ways to receive the same clinical approach
1.3 g L
[DOI] [PMC free article] [PubMed] [Google Scholar] 62.Marathe SJ, Grey EW, Bohm MS, Joseph SC, Ramesh AV, Cottam MA, Idrees K, Wellen KE, Hasty AH, Rathmell JC, Makowski L